CRP and COVID-19: Although the prevalent view of COVID-19 pathophysiology implicates a hyperactive immune response (often characterized by increased CRP serum levels as well as coordinated production of other cytokines), it also seems plausible that a relative, baseline insufficiency of an innate immune factor, particularly in the early phase of exposure, could also result in increased morbidity.